Answer
Talquetamab (TALVEY) is not recommended during pregnancy or for women of childbearing potential not using contraception; pregnancy risk cannot be assessed from available human or animal data, and effects on the developing foetus are unknown.
Sources for this answer
- TALVEY 2 mg/mL solution for injectionJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked